Inventor
KRAHN THOMAS
DE22 patents
⚠️ This page may combine multiple inventors who share the name “KRAHN THOMAS”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
BAYER AG
11 patentsUS6984297B2Jan 10, 2006
Device for taking measurements of cells which are contained in a liquid environment
BAYER AG71 citations97
US7078417B2Jul 18, 2006
Substituted 2-thio-3,5-dicyano-4-phenyl-6-aminopyridines with adenosine receptor-binding activity and their use as cardiovascular preparations
BAYER AG59 citations96
US7045631B2May 16, 2006
Substituted 2-thio-3, 5-dicyano-4-phenyl-6-aminopyridines and their use as adenosine receptor-selective ligands
BAYER AG53 citations95
US7129255B2Oct 31, 2006
Substituted 2-carba-3,5-dicyano-4-aryl-6-aminopyridines and the use of the same as selective ligands of the adenosine receptor
BAYER AG55 citations92
US7135486B1Nov 14, 2006
Substituted 2-thio-3,5-dicyano-4-aryl-6-aminopyridines and the use thereof
BAYER AG35 citations91
US6984642B1Jan 10, 2006
Substituted phenylcyclohexane carboxylic acid amides and their use as adenosine uptake inhibitors
BAYER AG4 citations60
US6291515B1Sep 18, 2001
Use of efomycins
BAYER AG2 citations56
US6649618B2Nov 18, 2003
Substituted amidoalkyl-uracils and their use
BAYER AG1 citations51
US7074780B2Jul 11, 2006
Substituted phenylcyclohexanecarboxamides and their use
BAYER AG0 citations50
US6649616B2Nov 18, 2003
Substituted phenylcyclohexanecarboxamides and their use
BAYER AG1 citations50
US7125995B2Oct 24, 2006
Substituted amidoalkyl uracils and their use as inhibitors of the poly(adp-ribose) synthetase (PARS)
BAYER AG0 citations36
BAYER SCHERING PHARMA AG
4 patentsUS7855219B2Dec 21, 2010
Substituted 2-oxy-3,5-dicyano-4aryl-6-aminopyridines and use thereof
BAYER SCHERING PHARMA AG26 citations92
US7709504B2May 4, 2010
Use of Substituted 2-thio-3,5-dicyano-4-phenyl-6-aminopyridines in the treatment of nausea and vomiting
BAYER SCHERING PHARMA AG27 citations91
US7825255B2Nov 2, 2010
Adenosine receptor selective modulators
BAYER SCHERING PHARMA AG18 citations84
US7615376B2Nov 10, 2009
Masking background fluorescence and luminescence in the optical analysis of biomedical assays
BAYER SCHERING PHARMA AG5 citations73
BAYER HEALTHCARE AG
3 patentsUS7109218B2Sep 19, 2006
Substituted 2-thio-3,5-dicyano-4-phenyl-6-aminopyridines and the use of the same
BAYER HEALTHCARE AG61 citations96
US7138280B2Nov 21, 2006
Masking of the background fluorescence and luminescence in the optical analysis of biomedical assays
BAYER HEALTHCARE AG7 citations73
US7045544B2May 16, 2006
Substituted 2,5-diamidoindoles as ECE inhibitors for the treatment of cardiovascular diseases
BAYER HEALTHCARE AG6 citations61